Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Tandem Diabetes Care (TNDM)

Tandem Diabetes Care stockholders approve charter changes, 3,260,000 more plan shares

Neutral Impact 2 of 5 shareholder Written later

At its May 20, 2026 annual meeting, Tandem Diabetes Care stockholders approved charter amendments that allow removal of directors with or without cause and limit officer liability, and approved a 3,260,000-share increase to the 2023 Long-Term Incentive Plan. The company filed the amended charter with Delaware on May 21, 2026, and all nine director nominees were elected, though director Christopher Twomey received 7,034,208 against votes, far more than other nominees.

Key points

  • Stockholders approved the Section 141(k) amendment allowing director removal with or without cause, with 57,818,029 for and 126,025 against.
  • Officer exculpation amendment passed with 45,926,405 for and 9,043,831 against.
  • The 2023 Long-Term Incentive Plan increase of 3,260,000 shares was approved with 53,846,696 for and 1,108,529 against.
  • Amended charter was filed with Delaware on May 21, 2026.

The filing

CompanyTandem Diabetes Care (TNDM)
Form8-K, current report
Filed with the SECMay 21, 2026, 4:10 PM ET
Accession number0001438133-26-000070

Items reported: 3.03 Change to Shareholder Rights5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.